ERIS · Healthcare
The board meets on 26 Oct 2026 to approve the results. This page fills in when the numbers are filed.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹505 cr | ₹486 cr | ₹551 cr | ₹720 cr | ₹741 cr | ₹727 cr | ₹705 cr | ₹773 cr | ₹792 cr | ₹807 cr | ₹757 cr | ₹873 cr |
| YoY | — | — | — | +54% | +47% | +50% | +28% | +7% | +7% | +11% | +7% | +13% |
| EBITDA margin | 35.8% | 36.2% | 26.9% | 34.7% | 35.8% | 34.4% | 35.7% | 35.8% | 36.4% | 34.9% | 35.9% | 33.9% |
| Other income, % of PBT | 2% | 3% | 19% | 2% | 4% | 3% | 6% | 2% | 2% | −12% | 1% | 1% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 3% | 12% | −4% | 22% | 25% | 25% | 21% | 22% | 22% | 25% | — | 20% |
| Net profit | ₹122 cr | ₹101 cr | ₹80.0 cr | ₹90.0 cr | ₹96.0 cr | ₹87.0 cr | ₹102 cr | ₹125 cr | ₹134 cr | ₹109 cr | ₹279 cr | ₹143 cr |
| YoY | — | — | — | −4% | −21% | −14% | +27% | +39% | +40% | +25% | +174% | +14% |
| Core profit YoY | — | — | — | +3% | +1% | 0% | +95% | +38% | +37% | +45% | +30% | +13% |
| EPS | ₹9.07 | ₹7.55 | ₹5.22 | ₹6.12 | ₹6.73 | ₹6.15 | ₹6.89 | ₹8.66 | ₹8.82 | ₹7.32 | ₹20.33 | ₹10.28 |
| Flags | · | · | 1 | 1 | 1 | 1 | 1 | ✓ | 1 | 1 | 2 | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.